FDA DrugClass IINotable
FDA Recall: Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL
Description
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
Hazard
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
Remedy
11,407 units
Related Recalls
2026-06-17 · FDA_DRUG
FDA Recall: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile,
SUN PHARMACEUTICAL INDUSTRIES INC
2026-06-17 · FDA_DRUG
FDA Recall: Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured. by: Tow
Breckenridge Pharmaceutical, Inc.
2026-06-17 · FDA_DRUG
FDA Recall: GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured
Golden State Medical Supply Inc.
2026-06-17 · FDA_DRUG
FDA Recall: Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceutic
Amneal Pharmaceuticals, LLC